CCR2 and myeloid sarcoma: Importantly, MP pulse therapy of MS patients neither altered the abundance of CCR2+ monocytes nor the surface expression levels of the receptor (Figures 8A,B), indicating that the increased migration of monocytes toward CCL2 after MP treatment was unrelated to GC effects on the chemokine receptor itself.